Non-HDL-C/HDL-C ratio is associated with carotid plaque stability in general population: A cross-sectional study

Anran Wang1, Yapeng Li1, Lue Zhou1

  • 1Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Frontiers in Neurology
|October 3, 2022
PubMed

Insights

The non-high-density lipoprotein cholesterol (non-HDL-C)/high-density lipoprotein cholesterol (HDL-C) ratio is linked to carotid plaque stability. This lipid ratio may help identify individuals at higher risk for carotid plaque, a key factor in stroke development.

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research
  • Lipid Metabolism

Background:

  • Carotid atherosclerosis and unstable plaque rupture are significant contributors to stroke.
  • The non-high-density lipoprotein cholesterol (non-HDL-C)/high-density lipoprotein cholesterol (HDL-C) ratio integrates information on both atherogenic and anti-atherogenic particles.
  • Previous studies indicate an association between this lipid ratio and carotid atherosclerosis, but its link to plaque stability remains unexplored.

Purpose of the Study:

  • To investigate the association between the non-HDL-C/HDL-C ratio and carotid plaque stability.
  • To determine if this lipid ratio can serve as an indicator for high-risk carotid plaques.

Main Methods:

  • A cross-sectional study involving 27,436 urban workers (aged ≥20 years) undergoing health screening.
  • Carotid plaque stability assessed via ultrasonography.
  • Multinomial logistic regression models used to analyze the relationship between the non-HDL-C/HDL-C ratio and plaque stability, with results presented as odds ratios (ORs) and 95% confidence intervals (CIs).

Main Results:

  • Prevalence of both stable and unstable carotid plaque increased significantly with higher quartiles of the non-HDL-C/HDL-C ratio (p for trend < 0.001).
  • Mean non-HDL-C/HDL-C ratios were progressively higher in participants with unstable plaque, stable plaque, and no plaque (p < 0.001).
  • After adjusting for cardiovascular risk factors, the highest non-HDL-C/HDL-C ratio quartile was associated with increased odds of stable plaque (OR=1.70) and unstable plaque (OR=2.34) compared to no plaque. A significant association was also found between unstable plaque and stable plaque (OR=1.38).

Conclusions:

  • The non-HDL-C/HDL-C ratio demonstrates a significant association with carotid plaque stability.
  • This lipid ratio may serve as a valuable biomarker for the early detection of high-risk carotid plaques.
  • Findings support the potential clinical utility of the non-HDL-C/HDL-C ratio in cardiovascular risk assessment.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
107
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
23
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
269
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
646